SCHEMBL7344134

SCHEMBL7344134

CC(C)(C)NC(=O)c1ccncc1F

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
POLB P06746 2/20 0.53
APEX1 P27695 1/20 0.53
STIM1 Q13586 2/20 0.43
ORAI1 Q96D31 2/20 0.43
TRPC1 P48995 1/20 0.43
TRPC3 Q13507 1/20 0.43
SMN1; SMN2 Q16637 2/20 0.42
HPGD P15428 1/20 0.42
PREP P48147 1/20 0.41
FAP Q12884 1/20 0.41
ALOX5AP P20292 3/20 0.41
FEN1 P39748 3/20 0.41
HTT P42858 1/20 0.41
L3MBTL1 Q9Y468 1/20 0.40
KDM4C Q9H3R0 2/20 0.40
SYK P43405 1/20 0.40
RAB9A P51151 1/20 0.40
ABL1 P00519 1/20 0.39
KDM4E B2RXH2 1/20 0.39
ALDH1A1 P00352 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30064136 0.81 SIRT3 (0.43) POLBAPEX1SMN1; SMN2HPGDL3MBTL1
SCHEMBL1423953 0.81 SIRT3 (0.43) POLBAPEX1SMN1; SMN2HPGDL3MBTL1
SCHEMBL1423962 0.79 RAB9A (0.42) POLBAPEX1SMN1; SMN2HPGDKDM4C
SCHEMBL28828166 0.78 SIRT3 (0.56) POLBAPEX1SMN1; SMN2HPGDL3MBTL1
SCHEMBL28064901 0.78 POLB (0.57) POLBAPEX1SMN1; SMN2HPGDSYK
SCHEMBL2998183 0.77 KDM4E (0.50) STIM1ORAI1TRPC1TRPC3SMN1; SMN2
SCHEMBL24568249 0.77 PREP (0.55) STIM1ORAI1TRPC1TRPC3PREP
SCHEMBL30171323 0.77 HPGD (0.42) POLBAPEX1SMN1; SMN2HPGDSYK
SCHEMBL28948291 0.77 HPGD (0.42) POLBAPEX1SMN1; SMN2HPGDSYK
SCHEMBL17180153 0.77 TP53 (0.54) POLBSTIM1ORAI1TRPC1TRPC3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-1997036902-A1 TRANS-2,6-, 3,6- AND 4,6-DIAZA-5,6,6a,7,8,12b-HEXAHYDROBENZO[C]PHENANTHRENE COMPOUNDS AS DOPAMINE AGONISTS ABBOTT LABORATORIES (US) 1997-10-09 WO disclosed
US-5668141-A TREATMENT OF PSYCHOLOGICAL, NEUROLOGICAL AND CARDIOVASCULAR DISORDERS ABBOTT LABORATORIES (US) 1997-09-16 US disclosed